Parkinson’s Disease
For people exploring investigational options while continuing to work with their established medical and neurological care teams.

Parkinson’s · TBI · Neurological conditions · Brain health
A medically focused, investigational program for people exploring ibogaine in the context of neurological health, with careful screening and coordination of continuing care.
Ibogaine Tijuana program
Interest in ibogaine has expanded beyond addiction recovery into questions about neurological health. These questions deserve scientific humility, careful screening, and honest communication about what is known and what remains investigational.
This program is designed for people exploring ibogaine in the context of Parkinson’s disease, traumatic brain injury, other neurological conditions, or long-term brain health. It does not replace a neurologist, established treatment, rehabilitation, or ongoing medical care.
No improvement, reversal, or cure can be guaranteed. The clinical priority is to understand the person’s diagnosis, functional baseline, medications, cardiovascular status, neurological history, and individual risk before any treatment decision.
Who this program is designed for
Every diagnosis and history is different. The program begins by understanding the medical context rather than assuming that one protocol fits everyone.
For people exploring investigational options while continuing to work with their established medical and neurological care teams.
For people with a history of TBI whose symptoms, medications, seizure history, and functional needs require individualized review.
For applicants whose diagnosis and overall health require condition-specific assessment and, when appropriate, specialist input.
For people interested in a medically responsible conversation about cognition, lifestyle, wellbeing, and continuing care without exaggerated claims.
A medically focused approach
The program combines individualized evaluation, careful risk review, a controlled setting, and a plan that keeps established neurological care in view.
Review diagnosis, symptoms, functional changes, TBI or seizure history, prior evaluations, current care, and relevant medical records.
Evaluate prescriptions, supplements, interactions, contraindications, and any medication changes that must only occur under qualified medical direction.
Use medical history, ECG, laboratory testing, cardiovascular assessment, and additional testing when clinically indicated to inform eligibility.
Connect the retreat with neurology, primary care, rehabilitation, mental-health support, sleep, nutrition, movement, and realistic follow-up goals.
Preparation · Evaluation · Care · Integration
A responsible process protects continuity of care and makes room for an honest decision—including the decision not to proceed.
Gather the neurological history, diagnosis, records, current symptoms, medications, and personal goals.
Assess cardiovascular, neurological, laboratory, medication, and other individual risk factors.
Discuss findings, uncertainties, informed consent, and whether treatment can be considered responsibly.
If treatment proceeds, plan for recovery, follow-up, and coordination with appropriate medical professionals.
Safety & eligibility
Neurological interest does not remove ibogaine’s known medical risks. Cardiac risk remains central, and neurological diagnoses, seizure history, autonomic symptoms, medications, and other factors may affect eligibility.
No medication should be stopped or changed solely to qualify for treatment. Decisions about prescriptions and ongoing neurological care belong with qualified clinicians who understand the individual’s complete medical picture.
Confidential · Personalized · Medically focused
A confidential consultation can help clarify what records, testing, specialist input, and eligibility review may be needed before any decision.
Request a Medical Consultation